Thus, Fascin is a common biomarker for aggressive carcinomas, can be used as a histological marker of particular cancer subtypes, and may be a useful therapeutic target, given its low expression in non-malignant adult epithelial tissues [2]. This evidence concerns the gene FSCN1 and carcinoma.